Biotech Values

[iwfal]

PPHM -

What I do understand about this CRO fiasco is that it happens, not often, but when it does the quilty CRO is responsible for doing a new trial.

True or dependent on the specific contract?

And what happens if there is a different CRO in India than in EE - and yet both have similar problems while showing stellar efficacy?

As for the particular legal question you asked - as someone noted it would depend upon the specifics of the contract.